MAT WAIVER Information

New Jersey ACEP is committed to serving our communities and promoting rapid access to buprenorphine and other appropriate treatments for patients struggling with opioid use disorder.  NJ-ACEP recognizes the increasing mortality from opioid overdose and supports buprenorphine initiation in the emergency department for the treatment of opioid use disorder.  We strongly encourage all emergency departments in New Jersey to integrate buprenorphine into their patient treatment options. We will work to promote buprenorphine education, mentorship, and transition of care for all emergency physicians in the state.


Waiver trainings: 

Physicians, residents, APRNs, PAs and medical students from all over the US are eligible for the course. Medical Students taking this course and apply for a waiver once they get their medical license, The course completion certificate does not expire.

Attendees signing up will attend a free, live, 4 hour virtual/remote webinar via computer taught by a clinical expert. Once completed, participants will receive the second half of the course – a 4 hour online self-study portion. At the end of the course, participants are required to pass an exam with a 75% or higher before applying for their waiver.

Tuesday, May 11th from 10 am- 2 pm

Thursday, June 10th from 5 pm- 9 pm

Wednesday, July 21st from 9 am- 1pm

Tuesday, October 5th from 5 pm-9 pm


Refresher courses:

This is a summarized 90 min refresher course for the EM MAT Waiver Training. Please note this is not part of the waiver training and attending this course does not count towards the official DEA X-waiver.

Tuesday, June 15th from 10 am – 11:30 am

Thursday, September 9th from 8 pm-9:30 pm


PCSS Funding information:

DATA 2000 Sponsor: American Academy of Addiction Psychiatry

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human ServicesÍž nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

PCSS website link:

Contact information: [email protected]